An analysis by Avalere suggests that government health programs will spend $50 billion over the next ten years just on ten new specialty drugs,including hepatitis C, cancer and cholesterol lowering medications.
Where to start? In a surge of untouched innocence, investors have provided Virgin Pulse with $92 million, that's right, $92 million, to support its "next-generation" employee well-being platform.
A study published in the Annals of Internal Medicine finds differences in patients readmitted soon after hospital discharge versus those readmitted later in a 30-day window, informing strategies to prevent readmissions.
http://annals.org/article.aspx?articleid=2299852
Jun042015
Packing in some more capital, PillPack has raised $50 million to build pharmacies that use its technology to customize medication packages.
For reasons that only it could possibly fathom, drug maker Teva has apparently invested tens of millions in American Well, another commodity provider of telemedicine services.
McKesson has completed the sale of its care management business to private equity firm Comvest Partners and Mosaic Health. The business will be named AxisPoint Health.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.